vidarabine has been researched along with Hypergammaglobulinemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assanasen, T; Polprasert, C; Prayongratana, K; Wongchitrat, C | 1 |
| Chen, LY; Collins, D; Coupland, R; Fung, AT; Gerrie, AS; Maberley, D; Moloney, G; Rossman, D; White, V; Wong, PC | 1 |
| Bourikas, G; Kaloutsi, V; Margaritis, D; Pantelidou, D; Spanudakis, E; Tsatalas, C | 1 |
3 other study(ies) available for vidarabine and Hypergammaglobulinemia
| Article | Year |
|---|---|
Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antirheumatic Agents; Cyclophosphamide; Female; Humans; Hypergammaglobulinemia; Immunoglobulin A; Immunologic Factors; Liver Diseases; Rituximab; Thailand; Vidarabine; Waldenstrom Macroglobulinemia | 2009 |
IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Humans; Hypergammaglobulinemia; Immunoglobulin G; Immunologic Factors; Lacrimal Apparatus; Lymph Nodes; Lymphatic Diseases; Male; Retinal Degeneration; Rituximab; Vasculitis; Vidarabine | 2013 |
Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Topics: Antineoplastic Agents; Female; Humans; Hypergammaglobulinemia; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Middle Aged; Remission Induction; Vidarabine | 2003 |